Endo Int'l (ENDP) Tops Q1 EPS by 13c; Reaffirms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Endo Reports First-Quarter 2017 Financial Results
May 9, 2017 6:30 AM EDTDUBLIN, May 9, 2017 /PRNewswire/ --
First-quarter 2017 revenues increased 8 percent from prior year to $1,038 million First-quarter 2017 U.S. Generic Pharmaceuticals revenue increased 24 percent to $722 million First-quarter 2017 reported $0.74 diluted (GAAP) loss per share from continuing operations First-quarter 2017 adjusted diluted earnings per share (EPS) from continuing operations increased 14 percent to $1.23 First-quarter 2017 reported (GAAP) consolidated net loss of $174 million First-quarter 2017 adjusted EBITDA increased 21 percent to $478 million Company reaffirms 2017 full-year revenues, adjusted EBITDA and adjusted diluted EPS financial guidanceEndo International... More
